BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27355563)

  • 1. The Mammalian Hairless Protein as a DNA Binding Phosphoprotein.
    Brook L; Whitfield GK; Hsieh D; Bither RD; Hsieh JC
    J Cell Biochem; 2017 Feb; 118(2):341-350. PubMed ID: 27355563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21
    Sui Y; Wu T; Li F; Wang F; Cai Y; Jin J
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.
    Liu PY; Hsieh TY; Liu ST; Chang YL; Lin WS; Wang WM; Huang SM
    Exp Cell Res; 2011 Dec; 317(20):2925-37. PubMed ID: 22001409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairless regulates p53 target genes to exert tumor suppressive functions in glioblastoma.
    Brook L; Palade P; Maatough A; Whitfield GK; Emeterio LS; Hsieh D; Hsieh JC
    J Cell Biochem; 2019 Jan; 120(1):533-543. PubMed ID: 30191601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection.
    Bai L; Kao JY; Law DJ; Merchant JL
    Gastroenterology; 2006 Sep; 131(3):841-52. PubMed ID: 16952553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.
    Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA
    PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
    Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
    BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53.
    Zeng X; Levine AJ; Lu H
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6681-6. PubMed ID: 9618472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
    Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
    Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.
    Hill DA; de la Serna IL; Veal TM; Imbalzano AN
    J Cell Biochem; 2004 Apr; 91(5):987-98. PubMed ID: 15034933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of niemann-pick c1 gene expression by the 3'5'-cyclic adenosine monophosphate pathway in steroidogenic cells.
    Gévry NY; Lalli E; Sassone-Corsi P; Murphy BD
    Mol Endocrinol; 2003 Apr; 17(4):704-15. PubMed ID: 12554781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Hairless Protein Roles in Skin/Hair and Emerging Connections to Brain and Other Cancers.
    Maatough A; Whitfield GK; Brook L; Hsieh D; Palade P; Hsieh JC
    J Cell Biochem; 2018 Jan; 119(1):69-80. PubMed ID: 28543886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
    Torgeman A; Mor-Vaknin N; Zelin E; Ben-Aroya Z; Löchelt M; Flügel RM; Aboud M
    Virology; 2001 Mar; 281(1):10-20. PubMed ID: 11222091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.